Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The success of chemotherapy largely depends on the anticancer immune response triggered by tumor cells that succumb to immunogenic cell death (ICD). One of the hallmarks of ICD is premortem autophagy that facilitates the release of adenosine triphosphate from dying cancer cells and acts as a chemoattractant for dendritic cell precursors. Here, we show that the immune response induced by inoculation of cancer cells undergoing ICD in response to the anthracycline mitoxantrone (MTX) can be improved by a short-term fasting regimen (48 hours of starvation) and that this effect is reversed by systemic administration of the autophagy inhibitor dimethyl α-ketoglutarate. Tumor growth reduction by MTX treatment is known to depend on autophagy induction in cancer cells as well as on an intact immune system. We compared the antitumor effects of MTX on autophagy-competent cancers implanted in wild type (WT) or partially autophagy-deficient (Becn1± or Atg4b−/-) mice. While there was no difference in the tumor growth reducing effects of MTX on tumors evolving in WT, Becn1+/- and Atg4b−/- mice, we observed an increase in the toxicity of MTX on Atg4b−/- mice. These results suggest that autophagy in cancer cells (but less so in host cells) is rate-limiting for therapeutically relevant anticancer immune responses, yet has a major role in blunting the life-threatening toxicity of chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, overactivation of autophagy by time‐restricted fasting or fasting mimetic agents potentiates the anticancer activity of immunogenic cell death inducers when used as a standalone regimen (Pietrocola et al, 2016; Galluzzi et al, 2017b; Castoldi et al, 2019) or in combination with antibodies targeting CTLA4 (cytotoxic T lymphocyte‐associated protein 4) or the immunosuppressive molecule CD274”
From Autophagy in major human diseases (2021) · cites this paper as Castoldi et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 1×
“Major interventions on whole body physiology such as starvation or chemotherapy may impact on the autophagy system that – in teleological terms – aims at increasing the resilience of the organism against metabolic and toxic challenges.(30) In the context of cancer, autophagy induction may have oncopreventive and impro…”
BackgroundSelf-citationImmunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationThe role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“Starvation of mice for 48h causes a ~ 20% weight loss associated with a massive autophagic response in multiple distinct nucleated cell types.(16,23) We tested the effect of fasting on the capacity of mice to mount a protective immune response against cancer cells succumbing to ICD induced by mitoxantrone (MTX) in vit…”
BackgroundThe immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Self-citationCaspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512 · cited 1×
“In mouse models, tumor growth reduction by chemotherapeutic agents often is dependent on T lymphocytes, meaning that tumors evolving in mice that lack T cells do not decrease their progression upon injection of cytotoxicants.(1,2) One efficient way to stimulate such therapeutically relevant antitumor immune responses…”
BackgroundSelf-citationAutophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377 · cited 4×
“This latter phenomenon is linked to autophagy, which is required for optimal release of ATP from dying cancer cells.(3) For this reason, autophagy-deficient cancer cells fail to release ATP in response to chemotherapy and thus are unable to recruit DCs into the tumor bed and to elicit an anti-tumor immune response.”
BackgroundInfluentialSelf-citationPharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842 · cited 1×
“Apparently such partial autophagy defects do not cause a major immunosuppressive effect, supporting the idea that autophagy in the tumor cells (rather than autophagy in immune effectors) is relevant to the therapeutic outcome of immunogenic chemotherapy.(36,37) As a caveat, we must insist on the fact that the systemic…”
BackgroundSelf-citationFasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., Pistoia, V., Wei, M., Hwang, S., Merlino, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003293 · Cited by 715 · cited 1×
“In addition, starvation, which is one of the best-known inducers of autophagy, increases the resistance of mice against the toxic effects of anthracyclinebased chemotherapy at the same time that it improves tumor growth reduction.(20,34) This autophagy- or starvationmediated improvement of chemotherapeutic responses h…”
BackgroundMa, Y., Adjemian, S., Mattarollo, S. R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J. P., Hannani, D., Duret, H., Steegh, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.003 · Cited by 699 · cited 1×
“ATP is normally confined to the intracellular space, yet can be released from stressed and dying cells into the extracellular compartment where it interacts with purinergic receptors, in particular P2Y2 purinergic receptors to attract myeloid cells including dendritic cell (DC) precursors into the tumor bed.(13,14) Th…”
BackgroundSelf-citationAutophagy and autophagy-related proteins in the immune system
Shibutani, S. T., Saitoh, T., Nowag, H., Münz, C., & Yoshimori, T. (2015) · Nature Immunology · doi:10.1038/ni.3273 · Cited by 582 · cited 1×
“Indeed, knockout of non-redundant autophagy genes (such as Atg5 or Atg7) in the hematopoietic lineage (or more specifically in myeloid or lymphoid subsets) has a strong immunosuppressive effect due to the loss of stem cell functions and an irreversible loss of cellular fitness precluding in-depth analyses of such phen…”
Background
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationLin, Y.-X., Wang, Y., Ding, J., Jiang, A., Wang, J., Yu, M., Blake, S., Liu, S., Bieberich, C. J., Farokhzad, O. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba9772 · Cited by 250
“Autophagy-deficient mice fail to increase ATP release and cannot elicit antitumor immunity activation (63).”
BackgroundTrial watch: dendritic cell vaccination for cancer immunotherapy
Sprooten, J., Ceusters, J., Coosemans, A., Agostinis, P., De Vleeschouwer, S., Zitvogel, L., Kroemer, G., Galluzzi, L., & Garg, A. D. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1638212 · Cited by 146
Self-citationLévesque, S., Le Naour, J., Pietrocola, F., Paillet, J., Kremer, M., Castoldi, F., Baracco, E. E., Wang, Y., Vacchelli, E., Stoll, G., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1657375 · Cited by 86
Self-citationJiang, T., Chen, X., Ren, X., Yang, J., & Cheng, Y. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100752 · Cited by 73
Metadata
- Authors
- Castoldi, F., Vacchelli, E., Zitvogel, L., Maiuri, M. C., Pietrocola, F., & Kroemer, G.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Karolinska University Hospital (SE)
- Corresponding author
- Pietrocola, Federico
- ORCID
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2018-10
- Volume
- 8
- Issue
- 1
- Pages
- e1498285-e1498285
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- PMC
- PMC6287785
- OpenAlex
- W2894877625
- Cited by
- 33
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 5
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- OncoImmunology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Association pour la Recherche sur le Cancer
- Seerave Foundation
- E-Rare
- European Commission
- Agence Nationale de la Recherche (ANR-17-CE14-0030, ANR-16-RHUS-0008)
- Fondation Leducq
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Institut Universitaire de France
- Institut National Du Cancer
- European Research Area Network on Cardiovascular Diseases
- Labex Immuno-Oncology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- autophagy, immunogenic cell death, anthracycline chemotherapy, mitoxantrone, fasting, Beclin-1, ATG4B, chemotherapy toxicity, dendritic cells, tumor immunology, antitumor immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. https://app.cochat.ai/papers/10.1080/2162402x.2018.1498285
- The paper
- Castoldi, F., Vacchelli, E., Zitvogel, L., Maiuri, M. C., Pietrocola, F., & Kroemer, G. (2019). Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. OncoImmunology. https://doi.org/10.1080/2162402x.2018.1498285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.